BRIEF-Diurnal Group says primary endpoint met in Infacort late-stage study
July 11, 2016 at 02:48 AM EDT
* Positive headline data from pivotal study for Infacort in Europe for paediatric adrenal insufficiency (AI)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|